The goal is to help you focus on what you need to know about rising PSA levels so you can hold meaningful, regular dialogues with all members of your health care team as you find the treatment path thatвЂ™s right for you. ThereвЂ™s more to know about rising PSA after treatment. Should I consider joining a clinical trial?.Should we add a medical oncologist to my treatment team to gain an additional perspective on treating my disease?.Are there dietary changes that I could make to optimize my treatment?.If the hormone therapy stops working, what treatment options remain?.How long do the treatment effects of hormone therapy last?.If I initiate hormone therapy, will this make my PSA drop back to zero? Will we monitor my PSA over time to see if itвЂ™s working?.What are the benefits and drawbacks/side effects of hormone therapy? Are there things that I can do to minimize the side effects?.If you recommend that I initiate androgen deprivation therapy (вЂњhormone therapyвЂќ), how will this benefit me and slow down the growth of the cancer cells? Is this the optimal time to initiate this treatment?.Should I get a bone scan to see if the cancer has spread to my bones?.Am I a candidate for local вЂњsalvageвЂќ prostatectomy or radiation? Why or why not?.Can we (should we) chart the velocity or doubling time of my PSA? What can this tell us about my prognosis?.What is my PSA level now, and how will we monitor changes over time?.What does it mean that my PSA level is rising again?.Some of these men can still be cured with additional treatment, but some men develop a form of prostate cancer that, while not curable, remains TREATABLE for a very long time.Д«elow is a list of questions to ask when your PSA is rising after initial treatment. However, about 25%вЂ“33% of men with prostate cancer will experience a recurrence of their cancer after surgery or radiation. Home В» About Prostate Cancer В» Diagnosis & Staging of Prostate Cancer В» PSA Rising В» What to Ask When Your PSA Is Rising After Initial TreatmentДЇor the majority of men, prostate cancer is treatable and curable and does not come back after initial treatment. Support PCF in Your Workplace or Community.Featured The 28th Annual Scientific Retreat.Coffey вЂ“ Holden Prostate Cancer Academy.27th Annual Scientific Retreat вЂ“ Video Replays.Featured Get the latest updates in health & wellness research.Featured Sign up for NewsPulse today and get groundbreaking information.Featured The latest prostate cancer research info.Featured PCFвЂ™s blog covers a wide range of topics.When to Get Checked for Prostate Cancer.Maintaining Health During Androgen Deprivation Therapy.Additional Facts for African-American Men and Their Families.Health and Wellness: Living with Prostate Cancer, Part 2: Diet Recommendations.Health and Wellness: Living with Prostate Cancer.Precision Therapies for Prostate Cancer.What to Ask When Your PSA Is Rising After Initial Treatment.Localized or Locally Advanced Prostate Cancer.The Prostate-Specific Antigen (PSA) Test.Contemporary treatments in prostate cancer focal therapy. Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study. Hofman MS, Lawrentschuk N, Francis RJ, et al. Management of biochemical recurrence after primary curative treatment for prostate cancer: a review. doi:10.1016/j.urology.2019.12.025ДЄrtibani W, Porcaro AB, De Marco V, Cerruto MA, Siracusano S. Transrectal subharmonic ultrasound imaging for prostate cancer detection.

Detection of recurrent prostate cancer after radical prostatectomy: comparison of 11C-choline PET/CT with pelvic multiparametric MR imaging with endorectal coil. Axumin positron emission tomography: Novel agent for prostate cancer biochemical recurrence. Songmen S, Nepal P, Olsavsky T, Sapire J. Adjuvant leuprolide with or without docetaxel in patients with high-risk prostate cancer after radical prostatectomy (TAX-3501): important lessons for future trials. PSA bounce, prognosis, and clues to the radiation response. NCCN clinical practice guidelines in oncology (NCCN guidelines): Prostate cancer, version 2.2021. National Institutes of Health, National Cancer Institute. National Library of Medicine: MedlinePlus.

Psa doubling time survival rate